• Wed, January 3, 2024

Michael Petusky Maintained (ANIK) at Buy with Increased Target to $29 on, Jan 3rd, 2024

Michael Petusky of Barrington Research, Maintained "Anika Therapeutics, Inc." (ANIK) at Buy with Increased Target from $28 to $29 on, Jan 3rd, 2024.

Michael, nor any peers, have made any analyst calls on ANIK in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍